Fundraising Fox
Noetik
South San Francisco, US · Founded 2022 · Delaware corporation · 53 employees on LinkedIn · 15 known investors
Find your way into Noetik
301 people in our graph share verified history with the Noetik team — schools, employers, funds. One of them is your warm intro.
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets. The platform aims to improve clinical trial patient selection and expand the set of viable cancer targets in drug development.
Founders & leadership
Noetik was founded in 2022 by Jacob Rinaldi, Ronald Alfa, and Ron Alfa, MD, PhD.
Board
Investors · 15
How we know: biospace.com · Not right? Tell us
How we know: Breakout Labs's portfolio page · Not right? Tell us
How we know: Breakout Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: EPIC VENTURES's portfolio page · biospace.com · Not right? Tell us
How we know: Linearis Ventures's portfolio page · Not right? Tell us
How we know: biospace.com · Not right? Tell us
How we know: board seat on SEC Form D · biospace.com · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · biospace.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$62M disclosed across 3 rounds · 2022–2024
- $14MSeedSep 2023 · 2 sources
DCVC (lead), 11.2 Capital, Catalio Capital Management, CJNV BioVentures, Epic Ventures, Hummingbird Nomads Fund, Intermountain Ventures, North South Ventures, Zetta Venture Partners
Source ↗
▶$40MraisedAug 2024 · 20 investors · BiotechnologyRule 506(b)
- James HardimanDirector
- Jacob RinaldiExecutive Officer, Director, Promoter
- Ronald AlfaExecutive Officer, Director, Promoter
- Amy SchulmanDirector
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$8MraisedSep 2022 · 9 investors · BiotechnologyRule 506(b)
- Ronald AlfaExecutive Officer, Director, Promoter
- Jacob RinaldiExecutive Officer, Director, Promoter
- James HardimanDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Noetik went on to found or lead other companies.
Competitors · 2
by search overlap
Companies competing with Noetik for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Noetik do?
- Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets. The platform aims to improve clinical trial patient selection and expand the set of viable cancer targets in drug development.
- Who founded Noetik?
- Noetik was founded by Jacob Rinaldi, Ronald Alfa, Ron Alfa, MD, PhD in 2022.
- Who are Noetik's investors?
- Noetik's investors include 11.2 Capital, Breakout Labs, Breakout Ventures, Catalio Capital Management, LP, EPIC VENTURES, Linearis Ventures, North South Ventures, Wittington Ventures and 4 more.
- How much funding has Noetik raised?
- Noetik has disclosed $62M raised across 3 rounds.
- Where is Noetik headquartered?
- Noetik is headquartered in South San Francisco, US.